ALEJANDRO
FONOLLOSA CALDUCH
![Foto de ALEJANDRO](/img/nophoto.png)
![Foto de Universidad del País Vasco/Euskal Herriko Unibertsitatea](/img/noimage_org.png)
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaPublicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (23)
2024
-
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Seminars in Arthritis and Rheumatism, Vol. 66
2023
-
Spontaneous resolution of inflammatory epiretinal membrane: Case series and review of the literature
European Journal of Ophthalmology, Vol. 33, Núm. 1, pp. NP10-NP14
2022
-
Resultados de vida real en el tratamiento de la degeneración macular asociada a la edad neovascular con terapia anti-VEGF. Análisis de 122 pacientes de un solo centro
Archivos de la Sociedad Española de Oftalmologia, Vol. 97, Núm. 4, pp. 191-197
-
Vogt-Koyanagi-Harada disease in Spain
European Journal of Ophthalmology, Vol. 32, Núm. 3, pp. 1547-1554
2021
-
Plasma Rich in Growth Factors (PRGF) Increases the Number of Retinal Müller Glia in Culture but Not the Survival of Retinal Neurons
Frontiers in Pharmacology, Vol. 12
-
Síndrome de nefritis tubulointersticial y uveítis (TINU): reporte de casos de un solo centro
Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears, Vol. 29, Núm. 3
-
The Effect of Plasma Rich in Growth Factors on Microglial Migration, Macroglial Gliosis and Proliferation, and Neuronal Survival
Frontiers in Pharmacology, Vol. 12
2020
-
Adalimumab in Elderly Patients with Non-Infectious Uveitis. Safety and Efficacy
Ocular Immunology and Inflammation, pp. 1-8
-
Systemic Regulatory T Cells and IL-6 as Prognostic Factors for Anatomical Improvement of Uveitic Macular Edema
Frontiers in Immunology, Vol. 11
2019
-
Effect of somatostatin on human retinal pigment epithelial cells permeability
Experimental Eye Research, Vol. 184, pp. 15-23
-
Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study
Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 257, Núm. 11, pp. 2381-2390
-
Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis
PLoS ONE, Vol. 14, Núm. 1
2018
2017
-
Dabrafenib for cutaneous melanoma infiltrating the vitreous: regression of metastasis and occurrence of uveitis as a secondary effect
Journal of Ophthalmic Inflammation and Infection
2016
-
Clinical Manifestations and Outcomes of Syphilis-associated Uveitis in Northern Spain
Ocular Immunology and Inflammation, Vol. 24, Núm. 2, pp. 147-152
-
Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis
Journal of Ophthalmic Inflammation and Infection, Vol. 6, Núm. 1
-
Safety and efficacy of intravitreal dexamethasone implants in the management of macular edema secondary to infectious uveitis
Retina, Vol. 36, Núm. 9, pp. 1778-1785
2014
-
Macular hole secondary to toxoplasmic retinochoroiditis
International Ophthalmology, Vol. 34, Núm. 1, pp. 141-143
2012
-
Aproximación diagnóstica a las uveítis
Revista Clinica Espanola, Vol. 212, Núm. 9, pp. 442-452